Viewing Study NCT01799993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT01799993
Status: COMPLETED
Last Update Posted: 2018-07-23
First Post: 2013-02-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pneumonia, Bacterial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gram-negative pneumonia View
None Intubation View
None Mechanical ventilation View
None Amikacin View